Back to search results

Tirzepatide in PWS, HO and GNSO

Abroad (travel likely)RecruitingPHASE4

Conditions

Prader-Willi Syndrome · Hypothalamic Obesity · Obesity/Therapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's Minnesota, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Diabetes/Endocrinology Research Team) · endocrineresearch@childrensmn.org · 651-220-5730
    Contact: Principal Investigator (Jennifer Abuzzahab, MD)

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Martha Upchurch) · martha.upchurch@vumc.org · 6158754274
    Contact: Principal Investigator (Ashley Shoemaker, MD)

  • Seattle Children's Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Endocrine Research Team) · EndocrineResearch@seattlechildrens.org · 206-987-2540
    Contact: Principal Investigator (Grace Kim, MD)
    Parisa Salehi, MD (Sub-investigator)
    Melinda Pierce, MD (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)